
@novonordisk’s Wegovy HD (semaglutide 7.2 mg) got US approval last week 🇺🇸
No approved competitor consistently beats ~20.7% weight loss.
Strong fundamentals… yet the stock keeps slipping 📉
AGM on Mar 26 — I like it at these levels 👀
Is the market underestimating $NOVO here?
#stockmarket #dividendinvesting

English







